Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: a phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/18073472

Download in:

View as

General Info

PMID
18073472